Clinical Pharmacogenetics Implementation Consortium

来自维基百科,自由的百科全书

Found in articles
卡培他滨
卡培他滨
Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clinical Pharmacology
别嘌醇
别嘌醇
Lee MT. Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. Clinical Pharmacology
阿米替林
阿米替林
Ellingrod VL, Skaar TC, Müller DJ, Gaedigk A, Stingl JC. Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing
卡马西平
卡马西平
Berger R, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing. Clinical Pharmacology and